D70.1 Código facturable y específico Agranulocytosis secondary to cancer chemotherapy

ICD-10-CM D70.1 identifies “Agranulocytosis secondary to cancer chemotherapy” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Capítulo 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Instrucciones del código

Use additional code1

code for adverse effect, if applicable, to identify drug (T45.1X5)

Code also1

underlying neoplasm

Instrucciones de niveles superiores

D70 · Neutropenia

Includes2
  • agranulocytosis
  • decreased absolute neurophile count (ANC)
Excludes 12
  • neutropenic splenomegaly (D73.81)
  • transient neonatal neutropenia (P61.5)
Use additional code2
  • code for any associated:
  • fever (R50.81)
Code also1

, if applicable, mucositis (J34.81, K12.3-, K92.81, N76.81)

Capítulos 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Referencias del índice oficial

Referencias del índice oficial (8)

Agranulocytosis(chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious) (3)
Leukopenia (2)
Neutropenia, neutropenic(chronic) (genetic) (idiopathic) (immune) (infantile) (malignant) (pernicious) (splenic) (3)
Historial

Historial del código

Último cambio registrado · FY2024

ModificadoSin cambios
FY2024

Vigente desde

  • Cambios en instrucciones heredadas

Agranulocytosis secondary to cancer chemotherapy

Código de diagnóstico facturable

CDC/NCHS · FY2024

Todas las ediciones (19)

Todas las edicionesVigente desdeHistorial del código
FY20162015-10-01Primera aparición
FY20172016-10-01Cambios en instrucciones
FY20182017-10-01Sin cambios tabulares
FY20192018-10-01Sin cambios tabulares
FY20202019-10-01Sin cambios tabulares
FY2020 · April2020-04-01Sin cambios tabulares
FY20212020-10-01Sin cambios tabulares
FY2021 · 01-012021-01-01Sin cambios tabulares
FY20222021-10-01Sin cambios tabulares
FY2022 · 04-012022-04-01Sin cambios tabulares
FY20232022-10-01Sin cambios tabulares
FY2023 · 04-012023-04-01Sin cambios tabulares
FY20242023-10-01Cambios en instrucciones heredadas
FY2024 · 04-012024-04-01Sin cambios tabulares
FY20252024-10-01Sin cambios tabulares
FY2025 · 04-012025-04-01Sin cambios tabulares
FY20262025-10-01Sin cambios tabulares
FY2026 · April2026-04-01Sin cambios tabulares
FY20272026-10-01Sin cambios tabulares
Correspondencias históricas ICD-9 · 2018

Solo correspondencia histórica; no sustituye códigos automáticamente.

  • 288.03 · Aproximada

Esta entrada es un código completo en la edición seleccionada. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.